Interní Med. 2009; 11(5): 215-217

Viral hemorrhagic fevers

doc. MUDr. Ladislav Machala Ph.D
Infekční klinika, FN na Bulovce, Praha

Viral hemorrhagic fevers (VHF) are severe viral infections characterized by occurrence of hemorrhagic complications and high mortality.

They occur in mainly in tropical regions and are caused by virus of the families Filoviridae, Arenaviridae, Flaviviridae and Bunyaviridae.

The risk of import of VHF is in our conditions not high, but diagnostics of VHF would be difficult because of lack of experience among

our physicians. Also the possibilities of therapy, prophylaxis and vaccination are still very limited.

Keywords: viral hemorrhagic fever, filovirus, arenavirus, flavivirus, bunyavirus.

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Machala L. Viral hemorrhagic fevers. Interní Med. 2009;11(5):215-217.
Download citation

References

  1. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002; 287 (18): 2391-2405. Go to original source... Go to PubMed...
  2. Viral Hemorrhagic Fever (VHF): Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis. www.cidrap.umn.edu/cidrap/content/bt/vhf/biofacts/vhffactsheet.html, 2008.
  3. Pigott DC. Hemorrhagic fever viruses. Crit Care Clin 2005; 21 (4): 765-783. Go to original source... Go to PubMed...
  4. Bray M. Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol 2005; 17 (4): 399-403. Go to original source... Go to PubMed...
  5. Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis 2003; 188 (11): 1613-1617. Go to original source... Go to PubMed...
  6. Aleksandrowicz P, Wolf K, Falzarano D, et al. Viral haemorrhagic fever and vascular alterations. Hamostaseologie 2008; 28 (1-2): 77-84. Go to original source... Go to PubMed...
  7. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004; 4 (8): 487-498. Go to original source... Go to PubMed...
  8. Isaacson M. Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis 2001; 33 (10): 1707-1712. Go to original source... Go to PubMed...
  9. Crowcroft NS, Morgan D, Brown D. Viral haemorrhagic fevers in Europe-effective control requires a co-ordinated response. Euro Surveill 2002; 7 (3): 31-32. Go to original source... Go to PubMed...
  10. Bausch DG, Ksiazek TG. Viral hemorrhagic fevers including hantavirus pulmonary syndrome in the Americas. Clin Lab Med 2002; 22 (4): 981-1020, viii. Go to original source... Go to PubMed...
  11. Tesh RB. Viral hemorrhagic fevers of South America. Biomedica 2002; 22 (3): 287-95. Go to original source... Go to PubMed...
  12. Groseth A, Feldmann H, Strong JE. The ecology of Ebola virus. Trends Microbiol 2007; 15 (9): 408-416. Go to original source... Go to PubMed...
  13. Towner JS, Pourrut X, Albarino CG, et al. Marburg virus infection detected in a common African bat. PLoS ONE 2007; 2 (1): e764. Go to original source... Go to PubMed...
  14. Leffel EK, Reed DS. Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2004; 2 (3): 186-191. Go to original source... Go to PubMed...
  15. Curtis N. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses. Adv Exp Med Biol 2006; 582: 35-44. Go to original source... Go to PubMed...
  16. Fajfr M, Neubauerová V, Fajfrová J. Diferenciální diagnostika hemoragických horeček. Klin mikrobiol inf lék 2008; 14 (4): 133-137.
  17. Casillas AM, Nyamathi AM, Sosa A, et al. A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 2003; 4 (4): 268-275. Go to original source... Go to PubMed...
  18. Grolla A, Lucht A, Dick D, et al. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot 2005; 98 (3): 205-209.
  19. Feldmann H, Jones SM, Schnittler HJ, et al. Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs 2005; 6 (8): 823-830. Go to PubMed...
  20. Woodrow CJ, Eziefula AC, Agranoff D, et al. Early risk assessment for viral haemorrhagic fever: experience at the Hospital for Tropical Diseases, London, UK. J Infect 2007; 54 (1): 6-11. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.